- Home
- SIF vs GOVX Comparison
SIF vs GOVX Comparison
Compare SIF & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- GOVX
- Stock Information
- Founded
- SIF 1913
- GOVX 2001
- Country
- SIF United States
- GOVX United States
- Employees
- SIF N/A
- GOVX N/A
- Industry
- SIF Office Equipment/Supplies/Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- GOVX Health Care
- Exchange
- SIF Nasdaq
- GOVX Nasdaq
- Market Cap
- SIF 22.6M
- GOVX 19.5M
- IPO Year
- SIF N/A
- GOVX N/A
- Fundamental
- Price
- SIF $3.65
- GOVX $1.77
- Analyst Decision
- SIF
- GOVX Strong Buy
- Analyst Count
- SIF 0
- GOVX 5
- Target Price
- SIF N/A
- GOVX $14.20
- AVG Volume (30 Days)
- SIF 4.7K
- GOVX 562.0K
- Earning Date
- SIF 02-12-2025
- GOVX 02-27-2025
- Dividend Yield
- SIF N/A
- GOVX N/A
- EPS Growth
- SIF N/A
- GOVX N/A
- EPS
- SIF N/A
- GOVX N/A
- Revenue
- SIF $79,633,000.00
- GOVX $3,090,161.00
- Revenue This Year
- SIF N/A
- GOVX N/A
- Revenue Next Year
- SIF N/A
- GOVX $150.51
- P/E Ratio
- SIF N/A
- GOVX N/A
- Revenue Growth
- SIF 20.53
- GOVX N/A
- 52 Week Low
- SIF $2.90
- GOVX $1.09
- 52 Week High
- SIF $5.96
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- SIF 50.40
- GOVX 31.12
- Support Level
- SIF $3.57
- GOVX $1.85
- Resistance Level
- SIF $3.89
- GOVX $2.24
- Average True Range (ATR)
- SIF 0.12
- GOVX 0.16
- MACD
- SIF 0.02
- GOVX -0.03
- Stochastic Oscillator
- SIF 53.66
- GOVX 11.38
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.